Niki BioSolutions, Inc. (NIKI)
NIKINASDAQ-CMIndustrial Machinery/Components
$1.65
-0.0500 (-2.94%) today
Closed, Nov 13, 4:00 PM ET
- Market cap
- $4.85m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $1.42 to $17.20
- Average volume
- –
- Previous close
- $1.70
Financials
No quarterly figures from the source.
News
6 latest- Niki BioSolutions Enters Deal To Provide APOE Testing Services For Progressive Medical Research RTTNews · Jul 24, 2026
- Aptorum To Merge With DiamiR In All-stock Deal, Stock Up In Pre-market RTTNews · Jul 16, 2025
- Aptorum Group to Issue 1.5 Million Class A SharesTipRanks · Jan 7, 2025
- Aptorum Group Limited Announces $3 Million Registered Direct Offering of Class A Ordinary SharesQuiver Quantitative · Jan 2, 2025
- Aptorum Group announces pricing of $3M registered direct offeringTipRanks · Jan 2, 2025
- 3 Penny Stocks to Watch Now, 01/02/25TipRanks · Jan 2, 2025
The company
Niki BioSolutions is a clinical-stage life sciences company focused on addressing unmet medical needs by developing high-quality genomic and biomarker testing solutions for healthcare providers, research institutions, and life sciences organizations. Through its CLIA-certified, CAP-accredited laboratory, the Company combines proprietary technologies with scientific rigor to support precision medicine across a range of therapeutic areas. Niki BioSolutions collaborates with leading academic centers, disease foundations, and biopharmaceutical companies. For more information, please visit www.nikibiosolutions.com and connect with Niki BioSolutions on LinkedIn.
- Sector
- Industrials
- Industry
- Industrial Machinery/Components
- Exchange
- NASDAQ-CM
- Region
- Asia
- Website
- aptorumgroup.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.